SCHEMBL6405881

SCHEMBL6405881

C=CCN(C)CC=CCOc1ccc2c(c1)CCCN2C(=O)Nc1ccc(CCCC)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.45
LMNA P02545 3/20 0.45
NR3C1 P04150 2/20 0.43
MAPT P10636 5/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MOGAT2 Q3SYC2 1/20 0.40
LSS P48449 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
AVPR2 P30518 1/20 0.38
OXTR P30559 1/20 0.38
AVPR1A P37288 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404222 0.89 MAPT (0.54) TP53LMNANR3C1MAPTALDH1A1
SCHEMBL5639827 0.89 MEN1 (0.47) TP53MAPTALDH1A1MAPK1NPSR1
SCHEMBL5639831 0.89 MEN1 (0.47) TP53MAPTALDH1A1MAPK1NPSR1
SCHEMBL6398665 0.88 MAPT (0.44) TP53MAPTALDH1A1MAPK1NPSR1
SCHEMBL6399950 0.88 LSS (0.54) TP53MAPTALDH1A1MAPK1NPSR1
SCHEMBL6400961 0.88 TP53 (0.48) TP53LMNANR3C1MAPTALDH1A1
SCHEMBL6398639 0.87 FLT1 (0.48) TP53LMNAMAPTALDH1A1MAPK1
SCHEMBL6429144 0.87 FLT1 (0.48) TP53LMNAMAPTALDH1A1MAPK1
SCHEMBL6400044 0.86 MAPT (0.43) TP53MAPTALDH1A1MAPK1NPSR1
SCHEMBL5638027 0.83 LSS (0.44) TP53LMNANR3C1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050020624-A1 Dihydroindole and tetrahydroquinoline derivatives AEBI JOHANNES (CH) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020624-A1 Dihydroindole and tetrahydroquinoline derivatives CYP46A1, LSS, CYP51A1 TP53 488/4885LMNA 3715/4885NR3C1 3713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.